著者・編者edited by Katherine Fierlbeck, Janice Graham, and Matthew Herder
一般注記Content Type: text (rdacontent), Media Type: unmediated (rdamedia), Carrier Type: volume (rdacarrier)
Summary: "There is plenty of controversy surrounding pharmaceuticals, however it cannot be denied that it is both a socially beneficial and profit-making industry. Regulators are expected to ensure that the economic success of the pharmaceutical industry does not come at the expense of public safety, yet, regulators have also assumed a cooperative role by providing advice on regulation and by targeting unmet medical needs. Concerns over regulatory standards, conflicts of interest, and the manipulation of information on drug safety and effectiveness have led to public mistrust, and a greater need for transparency between pharmaceutical industry and government regulators. Transparency, Power, and Influence in the Pharmaceutical Industry evaluates the progress made in holding the pharmaceutical industry responsible for creating this sense of transparency in the industry, from development to market. The contributors to this volume examine the various mechanisms introduced to make the regulatory process more infor
Issued also in electronic format
Includes bibliographical references and index
連携機関・データベース国立情報学研究所 : CiNii Research
NACSIS書誌ID(NCID)https://ci.nii.ac.jp/ncid/BC13169250 : BC13169250